Health and Me

Rachel V Thomas

India Steadily Transforming Into A Global Bio-pharma Hub: Govt

India is already known as the 'Pharmacy of the world', supplying 60 percent of the world’s vaccines and 20 percent of generic medicines. The country is soon transforming into a global bio-pharma hub, said the government today.

To achieve this, the focus must be on biosimilars and specialty medicines, said J P Nadda, Union Minister for Health &amp; Family Welfare and Chemicals &amp; Fertilizers.

He said this while making a virtual address at the 9th edition of India Pharma 2026, the flagship event of the Department of Pharmaceuticals (DoP), under the Ministry of Chemicals &amp; Fertilizers, today in New Delhi.

<h2>Shift Towards Biologics and Biosimilars</h2>

Nadda emphasized that India has long been recognized as the “pharmacy of the world” due to its leadership in affordable generic medicines. However, the global landscape is now rapidly shifting towards biologics, biosimilars, and specialty medicines.

“In this evolving environment, India is well positioned not only to adapt but to emerge as a global leader,” he stated.

Nadda reaffirmed the government’s commitment to fostering innovation and boosting research capabilities with schemes such as:

<ul><li>Biopharma Shakti Initiative, with an outlay of Rs 10,000 crore, aimed at advancing capabilities in biopharmaceutical innovation.</li><li>The PRIP scheme for promoting research in </li><li>pharmaceuticals and medical technology.</li><li>The Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing </li><li>The development of bulk drug parks aims to enhance self-reliance and resilient supply chains.</li></ul>The Health Minister also reiterated the government’s commitment to affordable healthcare through initiatives such as the Pradhan Mantri Bharatiya Jan Aushadhi Pariyojana (PMBJP), which continues to expand access to quality medicines at affordable prices across the country.

<h2>Rising Global Demand For Biologics And Biosimilars</h2>

Further, Minister of State for Health &amp; Family Welfare and Chemicals &amp; Fertilizers, Anupriya Patel highlighted that India is undergoing a significant transition from being a global generics leader to an emerging biopharma innovation hub.

"India currently contributes nearly 20 percent of global generic medicines and meets around 70 percent of global vaccine demand, underscoring the country’s robust manufacturing capabilities,” Patel said.

Emphasizing future opportunities, she stated that the global demand for biologics and biosimilars is expanding rapidly, with the biosimilars market projected to reach USD 75 billion by 2030. 

She further pointed out that innovative drugs account for nearly 87 percent of the global pharmaceutical market value, underlining the need for India to intensify its focus on innovation-driven segments.

Patel also outlined the integration of artificial intelligence in drug discovery and development.

She emphasized the importance of strengthening human capital through premier institutions such as NIPERs and IITs to support advanced research and innovation.

The two-day conference was organized in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA).

To transform India into an “innovator for the world”, other government officials stressed the need to:

<ul><li>accelerate innovation timelines</li><li>strengthen startup ecosystems</li><li>build a robust infrastructure for clinical trials </li><li>advanced research</li><li>enhanced funding mechanisms</li><li>closer industry-government collaboration</li><li>development of skilled talent.</li></ul>

Health Conditions A-Z

health

india-steadily-transforming-into-a-global-bio-pharma-hub-govt

j p nadda

biopharma shakti initiative

generic medicines

indian pharmaceutical alliance

shift towards biologics

prip

nipers

anupriya patel

production linked incentive

pmbjp

death-toll-from-mystery-illness-in-rajasthan-climbs-to-13

Death Toll from Mystery Illness in Rajasthan Climbs to 13

amitabh-bachchan

Amitabh Bachchan's Anxiety Struggles: The Impact Of Not Working On Workaholics

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

India is already known as the 'Pharmacy of the world', supplying 60 percent of the world’s vaccines and 20 percent of generic medicines. The country is soon transforming into a global bio-pharma hub, said the government today. To achieve this, the focus must be on biosimilars and specialty medicines, said J P Nadda, Union Minister for Health & Family Welfare and Chemicals & Fertilizers. He said this while making a virtual address at the 9th edition of India Pharma 2026, the flagship event of the Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, today in New Delhi.Shift Towards Biologics and BiosimilarsNadda emphasized that India has long been recognized as the “pharmacy of the world” due to its leadership in affordable generic medicines. However, the global landscape is now rapidly shifting towards biologics, biosimilars, and specialty medicines. “In this evolving environment, India is well positioned not only to adapt but to emerge as a global leader,” he stated. Nadda reaffirmed the government’s commitment to fostering innovation and boosting research capabilities with schemes such as:Biopharma Shakti Initiative, with an outlay of Rs 10,000 crore, aimed at advancing capabilities in biopharmaceutical innovation.The PRIP scheme for promoting research in pharmaceuticals and medical technology.The Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing The development of bulk drug parks aims to enhance self-reliance and resilient supply chains.The Health Minister also reiterated the government’s commitment to affordable healthcare through initiatives such as the Pradhan Mantri Bharatiya Jan Aushadhi Pariyojana (PMBJP), which continues to expand access to quality medicines at affordable prices across the country. Rising Global Demand For Biologics And BiosimilarsFurther, Minister of State for Health & Family Welfare and Chemicals & Fertilizers, Anupriya Patel highlighted that India is undergoing a significant transition from being a global generics leader to an emerging biopharma innovation hub. "India currently contributes nearly 20 percent of global generic medicines and meets around 70 percent of global vaccine demand, underscoring the country’s robust manufacturing capabilities,” Patel said. Emphasizing future opportunities, she stated that the global demand for biologics and biosimilars is expanding rapidly, with the biosimilars market projected to reach USD 75 billion by 2030. She further pointed out that innovative drugs account for nearly 87 percent of the global pharmaceutical market value, underlining the need for India to intensify its focus on innovation-driven segments. Patel also outlined the integration of artificial intelligence in drug discovery and development. She emphasized the importance of strengthening human capital through premier institutions such as NIPERs and IITs to support advanced research and innovation. The two-day conference was organized in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA). To transform India into an “innovator for the world”, other government officials stressed the need to:accelerate innovation timelinesstrengthen startup ecosystemsbuild a robust infrastructure for clinical trials advanced researchenhanced funding mechanismscloser industry-government collaborationdevelopment of skilled talent.

india steadily transforming into a global bio-pharma hub: govt

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

India Steadily Transforming Into A Global Bio-pharma Hub: Govt

Death Toll from Mystery Illness in Rajasthan Climbs to 13

Amitabh Bachchan's Anxiety Struggles: The Impact Of Not Working On Workaholics

From Free Medicines To Nutrition Needs: India Supporting Women At Every Stage Of Life, Says PM Modi

Health Conditions A-Z

Death Toll from Mystery Illness in Rajasthan Climbs to 13

India Steadily Transforming Into A Global Bio-pharma Hub: Govt

Amitabh Bachchan's Anxiety Struggles: The Impact Of Not Working On Workaholics